Inhibrx
INBX
$34.39
Share price
0.26%
Change (1 day)
30.02%
Change (1 year)
Categories
EPS for Inhibrx (INBX)
EPS in 2023 (TTM): -$4.05
According to Inhibrx's latest financial reports the company's current EPS (TTM) is -$4.05. In 2022 the company made an earnings per share (EPS) of -$3.62 a decrease over its 2021 EPS that were of -$2.15.
EPS history for Inhibrx from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.05 | 11.88% |
| 2022 | -$3.62 | 68.37% |
| 2021 | -$2.15 | -11.87% |
| 2020 | -$2.44 | 36.64% |
| 2019 | -$1.79 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -46.17% | 🇺🇸 USA |